QuidelOrtho has announced that its Board of Directors has appointed Brian J Blaser as President and CEO. In addition, Mr. Blaser will also join the Board later this month as it expands from ten to eleven members.
"We are excited to welcome Brian as our new president, CEO and director,” said Kenneth F Buechler, PhD, Chairman of the Board. “Brian brings over 25 years of senior leadership experience in the in vitro diagnostics industry, including seven years of full responsibility for Abbott’s global diagnostics business. His proven track record of executing transformational strategies to streamline operations and driving revenue growth to dramatically improve profitability makes him an ideal leader to guide QuidelOrtho through its next phase of growth.”
Blaser most recently served as Executive Vice President, Diagnostic Products of Abbott Laboratories, where he oversaw the global diagnostics organisation, including core laboratory, point of care, rapid diagnostics, and molecular diagnostics businesses. Prior to that role, he held various strategic, operational, and diagnostic roles at Abbott, as well as previous leadership positions at the Ortho Clinical Diagnostics division of Johnson & Johnson, Eastman Kodak, and General Motors.
“I am honoured and excited to join QuidelOrtho as President and CEO during this pivotal point in the company’s journey. The company’s commitment to customer service and its dedication to improving healthcare outcomes align closely with my own values,” said Blaser. “I am eager to collaborate with the QuidelOrtho team to drive innovation and continued growth, while delivering value to customers, shareholders and employees.”
